Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis

OBJECTIVES: Soluble suppression of tumorigenicity 2 (sST2) is a member of the interleukin-1 receptor family. It is raised in various cardiovascular diseases, but its value in predicting disease severity or mortality outcomes has been controversial. Therefore, we conducted a systematic review and met...

Descripción completa

Detalles Bibliográficos
Autores principales: Ip, Christina, Luk, King Sum, Yuen, Vincent Lok Cheung, Chiang, Lorraine, Chan, Ching Ki, Ho, Kevin, Gong, Mengqi, Lee, Teddy Tai Loy, Leung, Keith Sai Kit, Roever, Leonardo, Bazoukis, George, Lampropoulos, Konstantinos, Li, Ka Hou Christien, Tse, Gary, Liu, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528731/
https://www.ncbi.nlm.nih.gov/pubmed/34712771
http://dx.doi.org/10.1016/j.ijcha.2021.100887

Ejemplares similares

Ejemplares similares